We are live on ! Find out more
PRCM

Pine River Capital Management Portfolio holdings

AUM $32.9M
1-Year Est. Return 4.47%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+4.47%
3 Year Est. Return
+108.42%
5 Year Est. Return
+124.09%
10 Year Est. Return
AUM
$5.81B
AUM Growth
+$5.2B
Cap. Flow
+$1.66B
Cap. Flow %
28.63%
Top 10 Hldgs %
61.91%
Holding
509
New
95
Increased
33
Reduced
180
Closed
111

Sector Composition

Rank Sector Weight
1 Consumer Staples 14.88%
2 Communication Services 10.99%
3 Energy 4.75%
4 Technology 4.54%
5 Healthcare 2.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEN icon
301
Franklin Resources
BEN
$17.2B
$723K 0.01%
20,324
ORI icon
302
Old Republic International
ORI
$10.7B
$722K 0.01%
40,994
-40,540
-50% -$771K
COR icon
303
Cencora
COR
$62.2B
$721K 0.01%
8,929
-300
-3% -$25.7K
EAGLW
304
DELISTED
Double Eagle Acquisition Corp. Warrant
EAGLW
$720K 0.01%
1,800,000
GS icon
305
Goldman Sachs
GS
$307B
$719K 0.01%
4,457
-500
-10% -$81.3K
WFC icon
306
Wells Fargo
WFC
$263B
$718K 0.01%
16,222
-2,000
-11% -$95.7K
TRHC
307
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$716K 0.01%
+50,000
New +$730K
GILD icon
308
Gilead Sciences
GILD
$167B
$715K 0.01%
+9,039
New +$734K
KR icon
309
Kroger
KR
$36.4B
$712K 0.01%
23,983
-4,600
-16% -$153K
CLACW
310
DELISTED
Capitol Acquisition Corp. III Warrants
CLACW
$700K 0.01%
1,000,000
MLKN icon
311
MillerKnoll
MLKN
$1.6B
$662K 0.01%
+23,150
New +$764K
SFLY
312
DELISTED
Shutterfly, Inc.
SFLY
$655K 0.01%
+14,671
New +$728K
VOYA icon
313
Voya Financial
VOYA
$9.04B
$639K 0.01%
22,182
SVA
314
DELISTED
Sinovac Biotech, Ltd
SVA
$627K 0.01%
106,198
-441,701
-81% -$2.6M
MDSO
315
DELISTED
Medidata Solutions, Inc.
MDSO
$625K 0.01%
+11,200
New +$593K
BLVDW
316
DELISTED
Boulevard Acquisition Corp. II Warrant
BLVDW
$487K 0.01%
855,100
APTI
317
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$434K 0.01%
+20,000
New +$439K
ELECW
318
DELISTED
Electrum Special Acquisition Corporation
ELECW
$396K 0.01%
1,617,500
HCM icon
319
HUTCHMED
HCM
$1.93B
$341K 0.01%
+28,641
New +$366K
CCM
320
Concord Medical Services
CCM
$20.5M
$232K ﹤0.01%
+5,840
New +$245K
QPACW
321
DELISTED
Quinpario Acquisition Corp. 2 Warrant
QPACW
$214K ﹤0.01%
1,222,482
BIOA.WS
322
DELISTED
BioAmber Inc.
BIOA.WS
$163K ﹤0.01%
344,656
-5,145
-1% -$2.17K
ANH
323
DELISTED
Anworth Mortgage Asset Corporation
ANH
$151K ﹤0.01%
+30,648
New +$150K
PACEW
324
DELISTED
Pace Holdings Corp. Warrants
PACEW
$126K ﹤0.01%
300,000
-1,800,000
-86% -$636K
AGFSW
325
DELISTED
AgroFresh Solutions Inc Warrants
AGFSW
$118K ﹤0.01%
151,000
-350
-0.2% -$298

Similar funds

Pine River Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Pine River Capital Management held 509 positions worth $5.81B, up 848% from $613M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Pine River Capital Management deployed $1.66B of net new capital in Q3 2016, opening 95 new positions and adding to 33 existing holdings. Its largest new stake was Coty: 3,314,826 shares worth $76.9M.

By sector, the portfolio is most concentrated in Consumer Staples at 15% of assets, up from 0.02% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Booking.com, an estimated $47.2M trimmed.

  • Pine River Capital Management's largest Q3 2016 buy was Coty: 3,314,826 shares worth $76.9M.
  • Pine River Capital Management added most to Procter & Gamble in Q3 2016, an estimated $608M increase.
  • Pine River Capital Management's biggest Q3 2016 reduction was Booking.com, cutting an estimated $47.2M.
  • Pine River Capital Management fully exited E HOUSE (CHINA) HOLDINGS LIMITED in Q3 2016, selling an estimated $34.3M.
  • Pine River Capital Management's ten largest holdings make up 62% of its $5.81B portfolio in Q3 2016.
  • Pine River Capital Management opened 95 new positions and closed 111 in Q3 2016.
  • Pine River Capital Management's portfolio value rose 848% quarter-over-quarter to $5.81B.

Based on Pine River Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.